| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 79066 |
DOTA-MN2 2,2’-[4,10-双(2-{[2-(2-甲基-5-硝基-1H-咪唑-1-基)乙基]氨基}-2-氧乙基)-1,4,7,10-四氮杂环十二烷-1,7-二基]二乙酸 |
102 |
h |
2024-12-19 |
| 79067 |
cas:2123482-78-8，TETRAZINE-SS-BIOTIN 四嗪-双硫键-生物素 |
95 |
zyl |
2024-12-19 |
| 79068 |
GG-Tesirine，ADC定制 |
155 |
wyh |
2024-12-19 |
| 79069 |
DOTA-PEG-A20FMDV2 DOTA偶联聚乙二醇化的20个残基的线性肽 |
173 |
h |
2024-12-19 |
| 79070 |
MC-GGFG-Exatecan，ADC定制 |
174 |
wyh |
2024-12-19 |
| 79071 |
亲和素-AMF-DOTA(Nd) |
133 |
h |
2024-12-19 |
| 79072 |
DOTA偶联人血清白蛋白微球 DOTA-HSAM |
209 |
h |
2024-12-19 |
| 79073 |
MC-VA-PBD，MC-Val-Ala-PBD，ADC定制 |
246 |
wyh |
2024-12-19 |
| 79074 |
cas:2241685-22-1，DADPS Biotin Alykne |
118 |
zyl |
2024-12-19 |
| 79075 |
MC-vc-PAB-C6-Alpha-Amanitin，ADC定制 |
102 |
wyh |
2024-12-19 |
| 79076 |
MPB-MMAF，ADC定制 |
169 |
wyh |
2024-12-19 |
| 79077 |
DOTA–Bipy–RuII配位共轭物 |
222 |
h |
2024-12-19 |
| 79078 |
cas:1007215-91-9，1-(4-formylphenyl)-1-oxo-5,8,11-trioxa-2-azatridecan-13-oic acid |
144 |
zyl |
2024-12-19 |
| 79079 |
DOTA-cT84.66 DOTA偶联单克隆抗体cT84.66 |
108 |
h |
2024-12-19 |
| 79080 |
DOTA-Ahx-(D-Lys(6)-GnRH1)金属螯合剂DOTA偶联氨基己酸缀合D-赖氨酸 |
118 |
h |
2024-12-19 |
| 79081 |
DOTA-LRB 2-(6-(二乙基氨基)-3-(二乙基亚胺基)-3H-呫吨-9-基)-5-(N-(2-(2-(4,7,10-三(羧甲基)-1,4,7,10-四氮杂环十二烷-1-基)乙酰胺基 |
127 |
h |
2024-12-19 |
| 79082 |
DOTA-Y3-TATE DOTA偶联激动剂Y3-TATE |
127 |
h |
2024-12-19 |
| 79083 |
DOTA-2-脱氧-D-氨基葡萄糖 DOTA-DG |
165 |
h |
2024-12-19 |
| 79084 |
DOTA-c(RGDfK)DOTA偶联环肽 |
105 |
h |
2024-12-19 |
| 79085 |
SCN-DOTA-PCA DOTA-苯甲酰胺衍生物 |
135 |
h |
2024-12-19 |
| 79086 |
DOTA-N-羟基琥珀酰亚胺 DOTA-N-hydroxysuccinimide |
118 |
h |
2024-12-19 |
| 79087 |
低分子量CLT1肽靶向Gd(III)螯合物CLT1-dL-(Gd-DOTA) |
193 |
h |
2024-12-19 |
| 79088 |
DOTA-1,2-二硬脂酰-sn-甘油-3-磷酸乙醇胺脂质 |
180 |
h |
2024-12-19 |
| 79089 |
1,4,7-三氮杂环壬烷-1,4,7-三乙酸(NOTA17,19) |
127 |
h |
2024-12-19 |
| 79090 |
cas:1061569-06-9，4-formyl-N-(2-(2-hydroxyethoxy)ethyl)benzamide ADC抗体偶联药物 |
98 |
zyl |
2024-12-19 |
| 79091 |
DBCO-PEG4-VA-PBD，2241644-09-5，ADC定制 |
94 |
wyh |
2024-12-19 |
| 79092 |
Val-Cit-PAB-MMAE，cas:644981-35-1，ADC定制 |
115 |
wyh |
2024-12-19 |
| 79093 |
DOTA-GMSH 1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸(DOTA)偶联α-黑素细胞刺激素(α-MSH)类似物 |
125 |
h |
2024-12-19 |
| 79094 |
mDPR-Val-Cit-PAB-MMAE，1491152-26-1，ADC定制 |
105 |
wyh |
2024-12-19 |
| 79095 |
G3-(Gd-DTPA)(24)DOTA-钆(Gd)大分子造影剂 |
231 |
h |
2024-12-19 |
| 79096 |
DOTA-多柔比星 DOTA-DOX |
134 |
h |
2024-12-19 |
| 79097 |
聚(HPMA)-c(RGDyK)-DOTA |
94 |
h |
2024-12-19 |
| 79098 |
1,4,7,10-四氮杂环十二烷-1,4,7,10-四乙酸(DOTA)螯合剂共轭的应变环辛烯衍生物二苄基环辛烯(DBCO) |
113 |
h |
2024-12-19 |
| 79099 |
PDDEC-NB；2-methyl-2-(pyridin-2-yldisulfanyl)propyl 4-nitrophenyl carbonate |
100 |
zyl |
2024-12-19 |
| 79100 |
(67)Ga-DOTA复合物共轭二膦酸盐(67)Ga-DOTA-Bn-SCN-HBP |
163 |
h |
2024-12-19 |
| 79101 |
MWCNT/PEI-FI-DOTA(Gd)-PEG 异硫氰酸荧光素(FI)和钆(Gd)螯合剂共价接枝聚乙烯亚胺修饰的多壁碳纳米管 |
142 |
h |
2024-12-19 |
| 79102 |
DOTA-Cys-hAb47 螯合剂DOTA偶联半胱氨酸-抗EphB4抗体hAb47和hAb131 |
187 |
h |
2024-12-19 |
| 79103 |
1,4,7,10-四氮杂环十二烷-N,N,N,N-四乙酸(DOTA)-F(ab)2-曲妥珠单抗 |
142 |
h |
2024-12-19 |
| 79104 |
DOTA-MG11(DOTA-DGlu-Ala-Tyr-Gly-Trp-Met-Asp)DOTA肽缀合物 |
154 |
h |
2024-12-19 |
| 79105 |
AcLys-PABC-VC-Aur0101， cas:1438851-17-2，ADC定制 |
165 |
wyh |
2024-12-19 |
| 79106 |
cas:107348-47-0，2,5-dioxopyrrolidin-1-yl 3-(pyridin-2-yldisulfanyl)butanoate ADC抗体偶联药物 |
96 |
zyl |
2024-12-19 |
| 79107 |
SMCC-DM4 ， cas:1228105-52-9，ADC定制 |
100 |
wyh |
2024-12-19 |
| 79108 |
cas:1639939-40-4 Mal-Val-Ala-PAB-PNP |
105 |
zyl |
2024-12-19 |
| 79109 |
MA-PEG8-VA-PAB-SG3199，ADC定制 |
163 |
wyh |
2024-12-19 |
| 79110 |
Acid-PEG4-Val-Cit-PAB-MMAE |
93 |
zyl |
2024-12-19 |
齐岳微信公众号
官方微信
库存查询